Therapeutics MD

    0
    24
    RSS Source: https://www.therapeuticsmd.com/
    Default Action: directlink
    Default Link Follow: nofollow
    Default Link Target: newtab
    Feed Title: TherapeuticsMD Inc News Releases
    - TherapeuticsMD Inc News Releases

    -Executive Management to Host Conference Call on August 4, 2021 at 8:30 a.m. ET - BOCA RATON, Fla. --(BUSINESS WIRE)--Jul. 26, 2021-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced that it will report its second quarter 2021 financial results

    - TherapeuticsMD Inc News Releases

    BOCA RATON, Fla. --(BUSINESS WIRE)--May 25, 2021-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, announced today that the Company submitted a supplemental New Drug Application (“sNDA”) for BIJUVA (estradiol and progesterone) capsules, 0.5 mg/100 mg, to the

    - TherapeuticsMD Inc News Releases

    BOCA RATON, Fla. --(BUSINESS WIRE)--May 24, 2021-- TherapeuticsMD, Inc. (NASDAQ: TXMD), has been awarded a Top Workplaces 2021 honor by The Sun Sentinel . The list is based solely on employee feedback gathered through a third-party survey administered by employee engagement technology partner

    - TherapeuticsMD Inc News Releases

    - 1Q21 total net revenue increased to $19.9 million - - 1Q21 total net product revenue increased 60% to $19.6 million compared to 1Q20 - - ANNOVERA prescriptions continue to grow with increasing consumer support and acceptance - - Further strengthened ANNOVERA® patent family through June 2039 – -

    - TherapeuticsMD Inc News Releases

    -Poster included analyses of ANNOVERA Phase 3 menstrual bleeding profile data- BOCA RATON, Fla. --(BUSINESS WIRE)--May 3, 2021-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced Phase 3 menstrual bleeding profile data for ANNOVERA (segesterone acetate

    - TherapeuticsMD Inc News Releases

    Executive Management to Host Conference Call on May 6, 2021 at 8:30 a.m. ET BOCA RATON, Fla. --(BUSINESS WIRE)--Apr. 29, 2021-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that it will report its first quarter 2021 financial results on Thursday,

    - TherapeuticsMD Inc News Releases

    BOCA RATON, Fla. --(BUSINESS WIRE)--Apr. 8, 2021-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, and Theramex, a dedicated women’s health company, announced that BIJUVE ® has received approval from the Medicines and Healthcare products Regulatory Agency

    - TherapeuticsMD Inc News Releases

    - Full-year 2020 total net product revenue increased 84% to $62.9 million compared to 2019 - - 4Q20 total net product revenue increased 30% to $22.6 million compared to 3Q20 - - ANNOVERA ® net product revenue increased 42% for 4Q20 compared to 3Q20 - - Financing Agreement amended to update minimum

    - TherapeuticsMD Inc News Releases

    BOCA RATON, Fla. --(BUSINESS WIRE)--Mar. 1, 2021-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that the company will participate at the following investor conferences: Conference Cowen Virtual Healthcare Conference Date Wednesday, March 3, 2021

    - TherapeuticsMD Inc News Releases

    -Executive Management to Host Conference Call on March 2, 2021 at 8:30 a.m. ET - BOCA RATON, Fla. --(BUSINESS WIRE)--Feb. 23, 2021-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that it will report its fourth quarter 2020 financial results on

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here